A breakthrough in brain-targeted therapeutics: Researchers developed HX1 lipid nanoparticles that deliver mRNA and CRISPR gene-editing tools across the brain's protective barriers. Cryo-EM at CEMAS helped characterize the nanoparticles.
nature.com/articles/s4156…
nature.com/articles/s4156…